Global (United States, European Union and China) Measles Vaccine Market Research Report 2019-2025

Publisher Name :
Date: 06-Jun-2019
No. of pages: 119
Inquire Before Buying

In 2019, the market size of Measles Vaccine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Measles Vaccine.

This report studies the global market size of Measles Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Measles Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- GSK

- Sanofi-Pasteur

- Merck

- Novartis

- Pfizer

- Serum Institute of India

- China National Biotech Group

- Bavarian Nordic

- Emergent Biosolutions

- Medimmune

- Johnson & Johnson

- CSL Limited

Market Segment by Product Type

- Mumps Measles Rubella Vaccine, Live (MMR-II)

- Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Market Segment by Application

- Children

- Adults

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Measles Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Measles Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Measles Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Measles Vaccine Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Measles Vaccine Market Size Growth Rate by Type (2019-2025)
1.3.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.3.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.4 Market Segment by Application
1.4.1 Global Measles Vaccine Market Share by Application (2019-2025)
1.4.2 Children
1.4.3 Adults
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Measles Vaccine Market Size
2.1.1 Global Measles Vaccine Revenue 2014-2025
2.1.2 Global Measles Vaccine Sales 2014-2025
2.2 Measles Vaccine Growth Rate by Regions
2.2.1 Global Measles Vaccine Sales by Regions 2014-2019
2.2.2 Global Measles Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Measles Vaccine Sales by Manufacturers
3.1.1 Measles Vaccine Sales by Manufacturers 2014-2019
3.1.2 Measles Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Measles Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Measles Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Measles Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Measles Vaccine Price by Manufacturers
3.4 Key Manufacturers Measles Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Measles Vaccine Market
3.6 Key Manufacturers Measles Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Mumps Measles Rubella Vaccine, Live (MMR-II) Sales and Revenue (2014-2019)
4.1.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Sales and Revenue (2014-2019)
4.2 Global Measles Vaccine Sales Market Share by Type
4.3 Global Measles Vaccine Revenue Market Share by Type
4.4 Measles Vaccine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Measles Vaccine Sales by Application
6 United States
6.1 United States Measles Vaccine Breakdown Data by Company
6.2 United States Measles Vaccine Breakdown Data by Type
6.3 United States Measles Vaccine Breakdown Data by Application
7 European Union
7.1 European Union Measles Vaccine Breakdown Data by Company
7.2 European Union Measles Vaccine Breakdown Data by Type
7.3 European Union Measles Vaccine Breakdown Data by Application
8 China
8.1 China Measles Vaccine Breakdown Data by Company
8.2 China Measles Vaccine Breakdown Data by Type
8.3 China Measles Vaccine Breakdown Data by Application
9 Rest of World
9.1 Rest of World Measles Vaccine Breakdown Data by Company
9.2 Rest of World Measles Vaccine Breakdown Data by Type
9.3 Rest of World Measles Vaccine Breakdown Data by Application
9.4 Rest of World Measles Vaccine Breakdown Data by Countries
9.4.1 Rest of World Measles Vaccine Sales by Countries
9.4.2 Rest of World Measles Vaccine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Measles Vaccine
10.1.4 Measles Vaccine Product Introduction
10.1.5 GSK Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Measles Vaccine
10.2.4 Measles Vaccine Product Introduction
10.2.5 Sanofi-Pasteur Recent Development
10.3 Merck
10.3.1 Merck Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Measles Vaccine
10.3.4 Measles Vaccine Product Introduction
10.3.5 Merck Recent Development
10.4 Novartis
10.4.1 Novartis Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Measles Vaccine
10.4.4 Measles Vaccine Product Introduction
10.4.5 Novartis Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Measles Vaccine
10.5.4 Measles Vaccine Product Introduction
10.5.5 Pfizer Recent Development
10.6 Serum Institute of India
10.6.1 Serum Institute of India Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Measles Vaccine
10.6.4 Measles Vaccine Product Introduction
10.6.5 Serum Institute of India Recent Development
10.7 China National Biotech Group
10.7.1 China National Biotech Group Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Measles Vaccine
10.7.4 Measles Vaccine Product Introduction
10.7.5 China National Biotech Group Recent Development
10.8 Bavarian Nordic
10.8.1 Bavarian Nordic Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Measles Vaccine
10.8.4 Measles Vaccine Product Introduction
10.8.5 Bavarian Nordic Recent Development
10.9 Emergent Biosolutions
10.9.1 Emergent Biosolutions Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Measles Vaccine
10.9.4 Measles Vaccine Product Introduction
10.9.5 Emergent Biosolutions Recent Development
10.10 Medimmune
10.10.1 Medimmune Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Measles Vaccine
10.10.4 Measles Vaccine Product Introduction
10.10.5 Medimmune Recent Development
10.11 Johnson & Johnson
10.12 CSL Limited
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Measles Vaccine Sales Channels
11.2.2 Measles Vaccine Distributors
11.3 Measles Vaccine Customers
12 Market Forecast
12.1 Global Measles Vaccine Sales and Revenue Forecast 2019-2025
12.2 Global Measles Vaccine Sales Forecast by Type
12.3 Global Measles Vaccine Sales Forecast by Application
12.4 Measles Vaccine Forecast by Regions
12.4.1 Global Measles Vaccine Sales Forecast by Regions 2019-2025
12.4.2 Global Measles Vaccine Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Measles Vaccine Product Picture
Table Measles Vaccine Key Market Segments
Table Major Manufacturers Measles Vaccine Covered in This Report
Table Global Measles Vaccine Market Size Growth Rate by Type 2019-2025 (K Pcs) & (Million US$)
Figure Global Measles Vaccine Sales Market Shar by Type 2014-2025
Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Figures
Table Major Manufacturers of Mumps Measles Rubella Vaccine, Live (MMR-II)
Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Figures
Table Major Manufacturers of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Table Global Measles Vaccine Market Share by Application 2019-2025 (K Pcs)
Figure Children Use Case
Figure Adults Use Case
Figure Measles Vaccine Report Years Considered
Figure Global Measles Vaccine Market Size 2014-2025 (Million US$)
Figure Global Measles Vaccine Sales 2014-2019 (K Pcs)
Table Global Measles Vaccine Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Measles Vaccine Sales by Regions 2014-2019 (K Pcs)
Table Global Measles Vaccine Sales Market Share by Regions 2014-2019
Figure Global Measles Vaccine Sales Market Share by Regions 2014-2019
Figure Global Measles Vaccine Sales Market Share by Regions in 2019
Table Global Measles Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Measles Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Measles Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Measles Vaccine Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Measles Vaccine Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Measles Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Measles Vaccine Sales Share by Manufacturers in 2019
Table Measles Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Measles Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Measles Vaccine Value Share by Manufacturers in 2019
Table Global Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Measles Vaccine Price (2014-2019) (USD/Pcs)
Table Key Manufacturers Measles Vaccine Plants/Factories Distribution
Table Key Manufacturers Measles Vaccine Area Served
Table Date of Key Manufacturers Enter into Measles Vaccine Market
Table Key Manufacturers Measles Vaccine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Mumps Measles Rubella Vaccine, Live (MMR-II) Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Measles Vaccine Sales by Type (2014-2019) (K Pcs)
Table Global Measles Vaccine Sales Share by Type (2014-2019)
Figure Global Measles Vaccine Sales Market Share by Type (2014-2019)
Figure Global Measles Vaccine Sales Market Share by Type in 2018
Table Global Measles Vaccine Revenue by Type (2014-2019) (Million US$)
Table Global Measles Vaccine Revenue Share by Type (2014-2019)
Figure Global Measles Vaccine Revenue Market Share by Type (2014-2019)
Figure Global Measles Vaccine Revenue Market Share by Type in 2018
Table Measles Vaccine Price by Type 2014-2019 (USD/Pcs)
Table Global Measles Vaccine Sales by Application (2014-2019) (K Pcs)
Table Global Measles Vaccine Sales Share by Application (2014-2019)
Figure Global Sales Measles Vaccine Market Share by Application (2014-2019)
Figure Global Sales Measles Vaccine Market Share by Application (2014-2019)
Figure United States Measles Vaccine Sales Growth Rate 2014-2019 (K Pcs)
Figure United States Measles Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table United States Measles Vaccine Sales by Company (2014-2019) (K Pcs)
Table United States Measles Vaccine Sales Market Share by Company (2014-2019)
Figure United States Measles Vaccine Sales Market Share by Company in 2019
Table United States Measles Vaccine Sales by Type (2014-2019) (K Pcs)
Table United States Measles Vaccine Sales Market Share by Type (2014-2019)
Figure United States Measles Vaccine Market Share by Type in 2019
Table United States Measles Vaccine Sales by Application (2014-2019) (K Pcs)
Table United States Measles Vaccine Sales Market Share by Application (2014-2019)
Figure United States Measles Vaccine Market Share by Application in 2019
Figure European Union Measles Vaccine Sales Growth Rate 2014-2019 (K Pcs)
Figure European Union Measles Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Measles Vaccine Sales by Company (2014-2019) (K Pcs)
Table European Union Measles Vaccine Sales Market Share by Company (2014-2019)
Figure European Union Measles Vaccine Sales Market Share by Company in 2019
Table European Union Measles Vaccine Sales by Type (2014-2019) (K Pcs)
Table European Union Measles Vaccine Sales Market Share by Type (2014-2019)
Figure 2018 European Union Measles Vaccine Market Share by Type
Table European Union Measles Vaccine Sales by Application (2014-2019) (K Pcs)
Table European Union Measles Vaccine Sales Market Share by Application (2014-2019)
Figure 2018 European Union Measles Vaccine Market Share by Application
Figure China Measles Vaccine Sales Growth Rate 2014-2019 (K Pcs)
Figure China Measles Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table China Measles Vaccine Sales by Company (2014-2019) (K Pcs)
Table China Measles Vaccine Sales Market Share by Company (2014-2019)
Figure China Measles Vaccine Sales Market Share by Company in 2019
Table China Measles Vaccine Sales by Type (2014-2019) (K Pcs)
Table China Measles Vaccine Sales Market Share by Type (2014-2019)
Figure China Measles Vaccine Market Share by Type in 2019
Table China Measles Vaccine Sales by Application (2014-2019) (K Pcs)
Table China Measles Vaccine Sales Market Share by Application (2014-2019)
Figure China Measles Vaccine Market Share by Application in 2019
Figure Rest of World Measles Vaccine Sales Growth Rate 2014-2019 (K Pcs)
Figure Rest of World Measles Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Measles Vaccine Sales by Company (2014-2019) (K Pcs)
Table Rest of World Measles Vaccine Sales Market Share by Company (2014-2019)
Figure Rest of World Measles Vaccine Sales Market Share by Company in 2019
Table Rest of World Measles Vaccine Sales by Type (2014-2019) (K Pcs)
Table Rest of World Measles Vaccine Sales Market Share by Type (2014-2019)
Figure Rest of World Measles Vaccine Market Share by Type in 2019
Table Rest of World Measles Vaccine Sales by Application (2014-2019) (K Pcs)
Table Rest of World Measles Vaccine Sales Market Share by Application (2014-2019)
Figure Rest of World Measles Vaccine Market Share by Application in 2019
Table Rest of World Measles Vaccine Sales by Countries (2014-2019) (K Pcs)
Table Rest of World Measles Vaccine Sales Market Share by Countries (2014-2019)
Figure Rest of World Measles Vaccine Sales Market Share by Countries in 2019
Table Rest of World Measles Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Measles Vaccine Revenue Market Share by Countries (2014-2019)
Figure Rest of World Measles Vaccine Revenue Market Share by Countries in 2019
Figure Japan Measles Vaccine Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Measles Vaccine Revenue Growth Rate (2014-2019) (K Pcs)
Figure Korea Measles Vaccine Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Measles Vaccine Revenue Growth Rate (2014-2019) (K Pcs)
Figure India Measles Vaccine Sales Growth Rate (2014-2019) (K Pcs)
Figure India Measles Vaccine Revenue Growth Rate (2014-2019) (K Pcs)
Figure Southeast Asia Measles Vaccine Sales Growth Rate (2014-2019) (K Pcs)
Figure Southeast Asia Measles Vaccine Revenue Growth Rate (2014-2019) (K Pcs)
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table GSK Measles Vaccine Sales Growth Rate (2014-2019)
Table GSK Measles Vaccine Sales Market Share in Global Market
Table GSK Recent Development
Table Sanofi-Pasteur Company Details
Table Sanofi-Pasteur Description and Business Overview
Table Sanofi-Pasteur Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi-Pasteur Measles Vaccine Sales Growth Rate (2014-2019)
Table Sanofi-Pasteur Measles Vaccine Sales Market Share in Global Market
Table Sanofi-Pasteur Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck Measles Vaccine Sales Growth Rate (2014-2019)
Table Merck Measles Vaccine Sales Market Share in Global Market
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Measles Vaccine Sales Growth Rate (2014-2019)
Table Novartis Measles Vaccine Sales Market Share in Global Market
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Measles Vaccine Sales Growth Rate (2014-2019)
Table Pfizer Measles Vaccine Sales Market Share in Global Market
Table Pfizer Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Description and Business Overview
Table Serum Institute of India Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Serum Institute of India Measles Vaccine Sales Growth Rate (2014-2019)
Table Serum Institute of India Measles Vaccine Sales Market Share in Global Market
Table Serum Institute of India Recent Development
Table China National Biotech Group Company Details
Table China National Biotech Group Description and Business Overview
Table China National Biotech Group Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table China National Biotech Group Measles Vaccine Sales Growth Rate (2014-2019)
Table China National Biotech Group Measles Vaccine Sales Market Share in Global Market
Table China National Biotech Group Recent Development
Table Bavarian Nordic Company Details
Table Bavarian Nordic Description and Business Overview
Table Bavarian Nordic Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bavarian Nordic Measles Vaccine Sales Growth Rate (2014-2019)
Table Bavarian Nordic Measles Vaccine Sales Market Share in Global Market
Table Bavarian Nordic Recent Development
Table Emergent Biosolutions Company Details
Table Emergent Biosolutions Description and Business Overview
Table Emergent Biosolutions Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Emergent Biosolutions Measles Vaccine Sales Growth Rate (2014-2019)
Table Emergent Biosolutions Measles Vaccine Sales Market Share in Global Market
Table Emergent Biosolutions Recent Development
Table Medimmune Company Details
Table Medimmune Description and Business Overview
Table Medimmune Measles Vaccine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Medimmune Measles Vaccine Sales Growth Rate (2014-2019)
Table Medimmune Measles Vaccine Sales Market Share in Global Market
Table Medimmune Recent Development
Table Johnson & Johnson Company Details
Table CSL Limited Company Details
Figure Measles Vaccine Value Chain
Table Measles Vaccine Distributors List
Table Measles Vaccine Customers List
Table Global Measles Vaccine Sales Forecast 2019-2025 (K Pcs) & (Million US$)
Figure Global Measles Vaccine Sales Forecast 2019-2025 (K Pcs)
Figure Global Measles Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Global Measles Vaccine Sales Forecast by Type 2019-2025 (K Pcs)
Figure Global Measles Vaccine Sales Forecast by Type 2019-2025 (K Pcs)
Figure Global Measles Vaccine Sales Market Share Forecast by Type 2019-2025
Table Global Measles Vaccine Sales Forecast by Application 2019-2025 (K Pcs)
Figure Global Measles Vaccine Sales Forecast by Application 2019-2025 (K Pcs)
Figure Global Measles Vaccine Sales Market Share Forecast by Application 2019-2025
Table Global Measles Vaccine Sales Forecast by Regions 2019-2025 (K Pcs)
Figure Global Measles Vaccine Sales Forecast by Regions 2019-2025 (K Pcs)
Figure Global Measles Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Measles Vaccine Revenue Forecast by Regions 2019-2025 (K Pcs)
Figure Global Measles Vaccine Revenue Forecast by Regions 2019-2025 (K Pcs)
Figure Global Measles Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure United States Measles Vaccine Sales Forecast 2019-2025 (K Pcs)
Figure United States Measles Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure European Union Measles Vaccine Sales Forecast 2019-2025 (K Pcs)
Figure European Union Measles Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure China Measles Vaccine Sales Forecast 2019-2025 (K Pcs)
Figure China Measles Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Japan Measles Vaccine Sales Forecast 2019-2025 (K Pcs)
Figure Japan Measles Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Korea Measles Vaccine Sales Forecast 2019-2025 (K Pcs)
Figure Korea Measles Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure India Measles Vaccine Sales Forecast 2019-2025 (K Pcs)
Figure India Measles Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Measles Vaccine Sales Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Measles Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs